Medical Technology News

Drugs of Abuse Testing Market Size, Company Share Analysis and Forecast 2019-2026

Press release   •   Nov 04, 2019 10:33 EST

The global drugs of abuse testing market is expected to witness a consistent growth of 5.5% CAGR in the forecast period of 2018 to 2026. The global drugs of abuse testing market is expected to generate revenue of approximately US$7,163.7 mn by the end of the forecast period. Historical analysis of global drugs of abuse testing market states that by the end of 2017 the market generated the revenue of US$4,452.5 mn.

The report states that the growth of the market is also attributed to the rising incidences of drugs abuse in various developing countries. Furthermore, according to the analysis by the experts at Transparency Market Research the rising consumption of unsanctioned drugs by youth across the globe is another factor that is propelling the growth of global drugs of abuse testing market.

Experts believe that this consistent growth of global drugs of abuse testing market is a collective result of various opportunities leveraged by businesses in the market. Moreover, the analytics presented by the report is expected to help the business leaders take better decision and can prepare them for a tough competition that awaits in the future.

Request to Get Free Sample Copy of Report@ https://www.visionresearchreports.com/report/sample/29085

Growing Adoption of No Drugs Policies by Various Companies to Fuel the Growth

  • The growth of global drugs of abuse testing market is majorly the result of a growing concern of various corporate sectors to ensure good health of their employees. Also, the growth is also fueled by the growing government initiatives in various countries to confine the drugs abuse.
  • Moreover, the global drugs of abuse testing market is also influenced by the rising awareness about the adverse effects of non-prescribed drugs among the people in various countries.
  • Furthermore, the rising demand for equipment required to conduct the test is also promoting the growth of global drugs of abuse testing market.
  • Also, improving healthcare infrastructure in various emerging economies is another factor fueling the growth of global drugs of abuse testing market in the forecast period of 2018 to 2026.

The report analyzes and forecasts the drugs of abuse testing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global drugs of abuse testing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the drugs of abuse testing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of drugs of abuse testing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part of the report preparation. Those reading the report will be able to get a detailed understanding about the market. Industry experts have verified and checked the data and information that have been taken from credible sources like websites, annual reports of companies, journals, and other resources. In order give the facts and data a pictorial form, diagrams, graphs, pie charts, and other representations have been used. That augments the visual appeal of the report and makes understanding it much easier.

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29085

Key Players:

Various drug of abuse testing manufacturers and providers are focusing on creating awareness amongst the target population. The awareness is about the effects of drug abuse and importance of drug screening. Notable players functioning in drug of abuse testing market include Abbott Laboratories (Alere), Beckman Coulter (Danaher), Lab Corps of America Holdings, Drägerwerk AG & Co. KGaA, Quest Diagnostics, Randox Testing Services, United States Drug Testing Laboratories, Thermo Fisher Scientific, Siemens, and F. Hoffmann-La Roche Ltd.

Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market. This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.

Report coverage

  • Analysis Period: 2015 – 2026
  • Base Year: 2018
  • Forecast Data: 2019 – 2026
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Report Coverage: Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Report Segmentation

By Product

  • Analyzers
    • Breath analyzers
    • Immunoassay analyzers
    • Chromatographic analyzers
  • Rapid testing devices
  • Consumables

By Sample

  • Urine
  • Saliva
  • Hair
  • Others

By End-use

  • Hospitals
  • Forensic laboratories
  • Diagnostic laboratories
  • Law enforcement agencies
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia & Africa
    • South Africa
    • GCC Countries

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global drugs of abuse testing capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026)
  • Focuses on the key drugs of abuse testing manufacturers, to study the capacity, production, value, market share and development plans in future
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks
  • To identify significant trends and factors driving or inhibiting the market growth
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29085

Table of Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Drug of abuse testing industry 3600 synopsis, 2015 - 2026

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Sample trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Drug of Abuse Testing Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Favorable regulatory scenario in developed economies

3.3.1.2. Increasing usage of drug of abuse testing devices in law enforcement agencies

3.3.1.3. Growing number of clinical laboratories

3.3.1.4. Rising technological advancements

3.3.2. Industry pitfalls and challenges

3.3.2.1. Dearth of trained laboratory professionals

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By sample

3.4.3. By end-use

3.5. Porter’s analysis

3.6. Competitive landscape, 2018

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Drug of Abuse Testing Market, By Product

4.1. Key segment trends

4.2. Analyzers

4.2.1. Market size, by region, 2015 – 2026

4.2.2. Breath analyzers

4.2.2.1. Market size, by region, 2015 – 2026

4.2.3. Immunoassay analyzers

4.2.3.1. Market size, by region, 2015 – 2026

4.2.4. Chromatographic analyzers

4.2.4.1. Market size, by region, 2015 – 2026

4.3. Rapid testing devices

4.3.1. Market size, by region, 2015 – 2026

4.4. Consumables

4.4.1. Market size, by region, 2015 – 2026

Chapter 5. Drug of Abuse Testing Market, By Sample

5.1. Key segment trends

5.2. Urine

5.2.1. Market size, by region, 2015 – 2026

5.3. Saliva

5.3.1. Market size, by region, 2015 – 2026

5.4. Hair

5.4.1. Market size, by region, 2015 – 2026

5.5. Others

5.5.1. Market size, by region, 2015 – 2026

Chapter 6. Drug of Abuse Testing Market, By End-use

6.1. Key segment trends

6.2. Hospitals

6.2.1. Market size, by region, 2015 – 2026

6.3. Forensic laboratories

6.3.1. Market size, by region, 2015 – 2026

6.4. Diagnostic laboratories

6.4.1. Market size, by region, 2015 – 2026

6.5. Law enforcement agencies

6.5.1. Market size, by region, 2015 – 2026

Chapter 7. Drug of Abuse Testing Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market size, by country 2015 – 2026

7.2.2. Market size, by product, 2015 – 2026

7.2.2.1. Market size, by analyzers, 2015 – 2026

7.2.3. Market size, by sample, 2015 – 2026

7.2.4. Market size, by end-use, 2015 – 2026

7.2.5. U.S.

7.2.5.1. Market size, by product, 2015 – 2026

7.2.5.1.1. Market size, by analyzers, 2015 – 2026

7.2.5.2. Market size, by sample, 2015 – 2026

7.2.5.3. Market size, by end-use, 2015 – 2026

7.2.6. Canada

7.2.6.1. Market size, by product, 2015 – 2026

7.2.6.1.1. Market size, by analyzers, 2015 – 2026

7.2.6.2. Market size, by sample, 2015 – 2026

7.2.6.3. Market size, by end-use, 2015 – 2026

7.3. Europe

7.3.1. Market size, by country 2015 – 2026

7.3.2. Market size, by product, 2015 – 2026

7.3.2.1. Market size, by analyzers, 2015 – 2026

7.3.3. Market size, by sample, 2015 – 2026

7.3.4. Market size, by end-use, 2015 – 2026

7.3.5. Germany

7.3.5.1. Market size, by product, 2015 – 2026

7.3.5.1.1. Market size, by analyzers, 2015 – 2026

7.3.5.2. Market size, by sample, 2015 – 2026

7.3.5.3. Market size, by end-use, 2015 – 2026

7.3.6. UK

7.3.6.1. Market size, by product, 2015 – 2026

7.3.6.1.1. Market size, by analyzers, 2015 – 2026

7.3.6.2. Market size, by sample, 2015 – 2026

7.3.6.3. Market size, by end-use, 2015 – 2026

7.3.7. France

7.3.7.1. Market size, by product, 2015 – 2026

7.3.7.1.1. Market size, by analyzers, 2015 – 2026

7.3.7.2. Market size, by sample, 2015 – 2026

7.3.7.3. Market size, by end-use, 2015 – 2026

7.3.8. Italy

7.3.8.1. Market size, by product, 2015 – 2026

7.3.8.1.1. Market size, by analyzers, 2015 – 2026

7.3.8.2. Market size, by sample, 2015 – 2026

7.3.8.3. Market size, by end-use, 2015 – 2026

7.3.9. Spain

7.3.9.1. Market size, by product, 2015 – 2026

7.3.9.1.1. Market size, by analyzers, 2015 – 2026

7.3.9.2. Market size, by sample, 2015 – 2026

7.3.9.3. Market size, by end-use, 2015 – 2026

7.4. Asia Pacific

7.4.1. Market size, by country 2015 – 2026

7.4.2. Market size, by product, 2015 – 2026

7.4.2.1. Market size, by analyzers, 2015 – 2026

7.4.3. Market size, by sample, 2015 – 2026

7.4.4. Market size, by end-use, 2015 – 2026

7.4.5. Japan

7.4.5.1. Market size, by product, 2015 – 2026

7.4.5.1.1. Market size, by analyzers, 2015 – 2026

7.4.5.2. Market size, by sample, 2015 – 2026

7.4.5.3. Market size, by end-use, 2015 – 2026

7.4.6. China

7.4.6.1. Market size, by product, 2015 – 2026

7.4.6.1.1. Market size, by analyzers, 2015 – 2026

7.4.6.2. Market size, by sample, 2015 – 2026

7.4.6.3. Market size, by end-use, 2015 – 2026

7.4.7. India

7.4.7.1. Market size, by product, 2015 – 2026

7.4.7.1.1. Market size, by analyzers, 2015 – 2026

7.4.7.2. Market size, by sample, 2015 – 2026

7.4.7.3. Market size, by end-use, 2015 – 2026

7.4.8. Australia

7.4.8.1. Market size, by product, 2015 – 2026

7.4.8.1.1. Market size, by analyzers, 2015 – 2026

7.4.8.2. Market size, by sample, 2015 – 2026

7.4.8.3. Market size, by end-use, 2015 – 2026

7.5. Latin America

7.5.1. Market size, by country 2015 – 2026

7.5.2. Market size, by product, 2015 – 2026

7.5.2.1. Market size, by analyzers, 2015 – 2026

7.5.3. Market size, by sample, 2015 – 2026

7.5.4. Market size, by end-use, 2015 – 2026

7.5.5. Brazil

7.5.5.1. Market size, by product, 2015 – 2026

7.5.5.1.1. Market size, by analyzers, 2015 – 2026

7.5.5.2. Market size, by sample, 2015 – 2026

7.5.5.3. Market size, by end-use, 2015 – 2026

7.5.6. Mexico

7.5.6.1. Market size, by product, 2015 – 2026

7.5.6.1.1. Market size, by analyzers, 2015 – 2026

7.5.6.2. Market size, by sample, 2015 – 2026

7.5.6.3. Market size, by end-use, 2015 – 2026

7.6. MEA

7.6.1. Market size, by country 2015 – 2026

7.6.2. Market size, by product, 2015 – 2026

7.6.2.1. Market size, by analyzers, 2015 – 2026

7.6.3. Market size, by sample, 2015 – 2026

7.6.4. Market size, by end-use, 2015 – 2026

7.6.5. South Africa

7.6.5.1. Market size, by product, 2015 – 2026

7.6.5.1.1. Market size, by analyzers, 2015 – 2026

7.6.5.2. Market size, by sample, 2015 – 2026

7.6.5.3. Market size, by end-use, 2015 – 2026

7.6.6. GCC Countries

7.6.6.1. Market size, by product, 2015 – 2026

7.6.6.1.1. Market size, by analyzers, 2015 – 2026

7.6.6.2. Market size, by sample, 2015 – 2026

7.6.6.3. Market size, by end-use, 2015 – 2026

Chapter 8. Company Profiles

8.1. ALERE (Abbott )

8.1.1. Business overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. Danaher ( Beckman Coulter, Inc.)

8.2.1. Business overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. Drägerwerk AG & Co. KGaA

8.3.1. Business overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. F. Hoffmann-La Roche Ltd

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. LabCorp of America Holdings

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Quest Diagnostics Incorporated

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. Randox Testing Services

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. Siemens Healthcare Private Limited

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Thermo Fisher Scientific

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. United States Drug Testing Laboratories, Inc.

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. Strategic outlook

8.10.5. SWOT analysis

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29085

The homepage of Med-Tech Innovation. The central hub of all news related to medical devices, medical manufacturing and news for the medtech industry.